ClinicalTrials.gg
CompletedNCT00280891Updated Jan 28, 2013

Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

An observational study in Head and Neck Cancer, sponsored by Alberta Health services. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2013-01-28.

Sponsored by Alberta Health services · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Time perspective
Retrospective
Enrollment
100
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 202 studies in Head and Neck Neoplasms with a site in Canada — 32 open to participants now, 56 under way, 11 of them phase 3. Head and Neck Neoplasms · Canada.

Planned enrollment
13th of 24
100 · median 135
Started
2006
with 8 others
Observational
24 of 202
7 open now
Registered
36th of 202
by date

Among the 202 studies in Head and Neck Neoplasms with a site in Canada, this one is the 13th largest by planned enrollment of the 24 observational ones that give a count, is one of 9 that started in 2006, is one of 24 observational ones, and was the 36th registered.

Head and Neck Neoplasms

2,718 studies on the registry are indexed under Head and Neck Neoplasms; 599 are open to participants now.

Browse Head and Neck Neoplasms studies →

Open to participants now

32 of the 202 studies in Head and Neck Neoplasms with a site in Canada are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 458 Head and Neck Neoplasms studies recruiting now, 350 (76%) set no upper age limit and 51 (11%) stop at 75 or younger; 22 take children under 18; 27 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 202 studies in Head and Neck Neoplasms with a site in Canada, or all of them as a file.
02

Study summary

To describe the charactersitics of patients with advanced head and neck cancer treated with palliative intent and determine outcome in terms of symptom control and toxicity

03

Conditions studied

  • Head and Neck Cancer

Keywords

  • head and neck
  • cancer
  • palliation
  • radiotherapy
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • squamous cell carcinoma of the head and neck, primary treatment given with palliative intent

Exclusion criteria

Exclusion Criteria:

  • radical treatment, palliative treatment following local recurrence, adenocarcinoma, salivary gland carcinoma or melanoma
05

Study design

Time perspective
Retrospective
Enrollment
100 participants (estimated)
06

Study locations

1 site
  • Tom Baker Cancer Centre
    Calgary, Alberta T2N 4N2, Canada
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2006 and a completion of Jun 2006. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2006
First posted
Jan 24, 2006
Start
Jan 2006
CompletionActual
Jun 2006
Last update
Jan 28, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00280891
Lead sponsor
Alberta Health services
First posted
Jan 24, 2006
Start date
Jan 2006
Completion
Jun 2006
Last update
Jan 28, 2013

Study contacts

Harold Lau, MD
principal investigator · Alberta Cancerboard
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion